Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-06-28
1995-12-26
Datlow, Philip I.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 39, C07D22122, A21K 31435
Patent
active
054788340
ABSTRACT:
Novel aconitine compounds of the formula ##STR1## wherein the symbols are as defined in the description, as well as analgesic/anti-inflammatory agent containing them or salts thereof as active ingredient.
REFERENCES:
Chemical and Pharmaceutical Bulletin, vol. 39, No. 2, Feb. 1991, Tokyo JP, pp. 379-383; Mori et al: "Studies on the Constitutents of Aconitum Species.XII. Syntheses of Jesaconitine Derivatives and Their Analgesic and Toxic Activities".
Chemical Abstracts, vol. 116, No. 11, 16 Mar. 1992, Columbus, Ohio; Abstract No. 106574, p. 808; & JP-A-03 223 255 (Sanwa Seeiyaku Co. Ltd.) 2 Oct. 1991.
Grant & Hackh's Chemical Dictionary, 5th ed (1987), Roger Grant et al., p. 22.
Mori Takao
Murayama Mitsuo
Datlow Philip I.
Sanwa Shoyaku Kabushiki Kaisha
LandOfFree
Aconitine compounds and analgesic/anti-inflammatory agent contai does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aconitine compounds and analgesic/anti-inflammatory agent contai, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aconitine compounds and analgesic/anti-inflammatory agent contai will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1369401